RA Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $84.6M | Hold |
|
|||||
|
2024
Q3 | $89.9M | Hold |
|
|||||
|
2024
Q2 | $80.5M | Hold |
|
|||||
|
2024
Q1 | $79.8M | Hold |
|
|||||
|
2023
Q4 | $79.6M | Hold |
|
|||||
|
2023
Q3 | $69.9M | Hold |
|
|||||
|
2023
Q2 | $71.9M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $112M | Hold |
|
|||||
|
2021
Q1 | $93.7M | Hold |
|
|||||
|
2020
Q4 | $135M | Sell |
|
|||||
|
2020
Q3 | $145M | Hold |
|
|||||
|
2020
Q2 | $167M | Buy |
|
|||||
|
2020
Q1 | $112M | Buy |
|
|||||
|
2019
Q4 | $38M | Sell |
|
|||||
|
2019
Q3 | $13.4M | Sell |
|
|||||
|
2019
Q2 | $34.5M | Sell |
|
|||||
|
2019
Q1 | $46.9M | Buy |
|